Synergism of oxacillin and gentamicin against enterococci.

Antimicrobial Agents and Chemotherapy
R L MarierV T Andriole

Abstract

Strains of enterococci isolated from 34 patients were studied for susceptibility to oxacillin and gentamicin alone and in combination. The minimal bactericidal concentrations of oxacillin and gentamicin for these strains ranged from 16 to 250 mug/ml (median 32 mug/ml) for oxacillin and 12 to 48 mug/ml (median 24 mug/ml) for gentamicin. The minimal bactericidal concentration of oxacillin for 50% of strains in the presence of 12, 6, 3, and 1.5 mug of gentamicin per ml, respectively, was 2, 8, 16, and 32 mug/ml. The combination of oxacillin and gentamicin at clinically attainable serum levels was synergistically bactericidal against 27/34 (80%) of these strains using strict criteria. This report reconfirms the original observation that antibiotics which affect the synthesis of bacterial cell walls combine synergistically with aminoglycosides against enterococci. This is so even though enterococci are far more resistant to oxacillin than to penicillin or ampicillin. In addition, this report suggests that the combination of oxacillin and gentamicin administered in the usual dosages includes enterococci in its bactericidal spectrum.

References

Feb 26, 1973·JAMA : the Journal of the American Medical Association·A J Weinstein, R C Moellering
Aug 1, 1973·Antimicrobial Agents and Chemotherapy·C Watanakunakorn, C Bakie
Nov 1, 1973·Antimicrobial Agents and Chemotherapy·R D LibkeW M Kirby
Apr 1, 1969·The Journal of Infectious Diseases·J C GingellP M Waterworth
Aug 1, 1970·Archives of Internal Medicine·H D StandifordW M Kirby
Dec 1, 1971·The Journal of Infectious Diseases·V T Andriole
Dec 1, 1971·The Journal of Infectious Diseases·R C MoelleringA N Weinberg
Dec 1, 1971·The Journal of Infectious Diseases·C Watanakunakorn

❮ Previous
Next ❯

Citations

Oct 1, 1977·Antimicrobial Agents and Chemotherapy·L J LincolnE Abrutyn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.